cbdMD (YCBD) EBIT Growth (1y) (2017 - 2026)
cbdMD (YCBD) EBIT Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -150.77% |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -10.00% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -0.93% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | -9.25% |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -97.30% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 4.05% |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 12.73% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | cbdMD | 5.41 Mn | 3.29 Mn | 3.04 Mn | -24.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -24.96% |
| Dec 31, 2025 | -231.84% |
| Sep 30, 2025 | -116.65% |
| Jun 30, 2025 | -136.81% |
| Mar 31, 2025 | 68.68% |
| Dec 31, 2024 | 91.91% |
| Sep 30, 2024 | 97.92% |
| Jun 30, 2024 | 79.05% |
| Mar 31, 2024 | -10.73% |
| Dec 31, 2023 | 73.66% |
| Sep 30, 2023 | -1.56% |
| Jun 30, 2023 | 94.49% |
| Mar 31, 2023 | 72.05% |
| Dec 31, 2022 | 83.91% |
| Sep 30, 2022 | -113.66% |
| Jun 30, 2022 | -396.23% |
| Mar 31, 2022 | -20.22% |
| Dec 31, 2021 | -1,328.74% |
| Sep 30, 2021 | -54.77% |
| Jun 30, 2021 | -399.11% |